Skip to content

Clinical trials

Phase 1/2 Inflammation trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Country / region: Germany Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biotectid GmbH1
Charite University, Berlin, Germany1
Novartis1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation4
Acute Coronary Syndrome1
Arthritis1
Arthritis, Rheumatoid1
Asthma1
Autoimmune Diseases1
Multiple Sclerosis1
Multiple Sclerosis, Relapsing-Remitting1
Nerve Degeneration1
Rheumatic Diseases1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.